NCT05545020

Trivalent Chromium Treatment for Rheumatoid Arthritis

Trivalent Chromium as a Treatment for Rheumatoid Arthritis Patients

• Status: Completed
• Phase: Phase 2 / Phase 3
• Study type: Interventional
• Enrollment: 60 (actual)
• Sponsor: Alexandria University · Academic / Other
• Sex: All
• Age: 18 Years – 80 Years
• Healthy volunteers: Not accepted

Summary

Trivalent chromium has shown good results in abolishing inflammation and had a successful result in treating animal model of rheumatoid arthritis. In addition to that, trivalent chromium lacks many side effects which are related to the already known medications of the disease. So this study aims to evaluate the efficacy of trivalent chromium supplementation in rheumatoid arthritis treatment and measuring the outcomes of that in rheumatoid arthritis patients.

Detailed description

Rheumatoid arthritis is a debilitating autoimmune disease which is treated by medications that have many side effects. Trivalent chromium, a naturally occurring element with regulatory effects on blood sugar, has shown anti-inflammatory properties in many studies and has shown a good response at alleviation of rheumatoid arthritis in the disease animal model. For these reasons trivalent chromium should be tried in rheumatoid arthritis patients.

Conditions

• Rheumatoid Arthritis

Interventions

Type	Name	Description
DRUG	Trivalent chromium versus synthetic and/ or biological DMARDs	Supplement and immunesuppressants

Timeline

• Start date: 2022-12-25
• Primary completion: 2024-01-13
• Completion: 2024-01-13
• First posted: 2022-09-19
• Last updated: 2024-02-06

Locations

1 site across 1 country: Egypt